|

BPI-1178 Clinical Trials

2 actively recruiting trials

Also known as: BPI-1178 capsule

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • National Cancer Center, China1
  • Beta Pharma (Suzhou) Co., Ltd.1

Indications

  • Cancer2
  • HR+/HER2- Breast Cancer1
  • Advanced Solid Tumor1
  • NSCLC1
  • Lung Cancer1

Other2 trials

A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
Phase 1
A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.